The global antimicrobial susceptibility testing market was valued at $3,040.00 million in 2020, and is estimated to reach $4,736.03 million by 2030, growing at a CAGR of 5.8% from 2021 to 2030. Antimicrobial susceptibility testing (AST) plays a crucial role in the fight against infectious diseases by helping healthcare professionals determine the most effective antibiotics to treat …